Welcome

The Mississippi Society of Oncology was formed in 1991 for the purpose of promoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.

In addition,  the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.

And finally the MOS  acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.

____________________________________________________________

Announcements

New ASCO Policy Brief: Co-Pay Accumulators and Co-pay Maximizers
Co-pay accumulators and co-pay maximizers have been an area of concern amongst State Affiliate Council members.  ASCO has created a new informational policy brief to help explain these programs and provide guidance regarding its position as an organization.  The brief can be accessed by clicking below.

Click here for more.

-------------------------------------------------------------------------------------------------------

Report: Progress in Global Cancer Fight is Not Only Possible, but Achievable
The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

Click here for more.

-------------------------------------------------------------------------------------------------------

United Health and Optum 'Uniting Care and Coverage' in New Model
UnitedHealth Group and its Optum medical care provider business are rolling out a combined package of medical care and health insurance as they meld health benefits with the provision of healthcare services.

Click here for more.

-------------------------------------------------------------------------------------------------------

New Survey Seeks Provider Input on Clinical Trial Enrollment
ASCO is participating in a joint initiative from the American Cancer Society's Cancer Action Network in conjunction with the Association of Community Cancer Centers and the Oncology Nursing Society.  Click below to access the survey.

Click here for the survey

-------------------------------------------------------------------------------------------------------

Walmart to Measure Doctor Quality in Local Markets
Walmart is rolling out an effort to measure the quality of community doctors who treat tens of thousands of its employees in the retailer’s latest effort to make sure its workers get the right care, in the right place and at the right time.

Click here for more.

-------------------------------------------------------------------------------------------------------

CMS to Collect 340B Drug Cost Information
The CMS issued a notice on September 26th that it will collect information from hospitals participating in the 340B drug discount program about the prices they pay for eligible drugs.

Click here for more.

-------------------------------------------------------------------------------------------------------

Cancer Drugs Account for 27% of All New Drug Approvals in the US

Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010, a dramatic increase from the 4% share of the 1980s, a newly completed analysis from the Tufts Center for the Study of Drug Development shows.

Click here for more.

-------------------------------------------------------------------------------------------------------

Educate and Support Your Patients with ASCO Answers Materials
Recently, State Affiliate presidents and executive directors received a mailing from Cancer.Net that included patient education materials that you and your members may find useful. These materials, along with additional resources that can be found on Cancer.Net give your patients ASCO-approved information on diagnosis, treatment, side effects, and psychosocial effects of cancer.  The ASCO Answers series includes fact sheets, booklets on specific topics in cancer care, and comprehensive, patient-friendly guides. These easy-to-read materials cover breast cancer, colorectal cancer, non-small cell lung cancer, small cell lung cancer, prostate cancer, cancer survivorship, caregiving, palliative care, managing cancer-related pain, advanced cancer care planning, and much more.  ASCO members save 20 percent.  All orders include free domestic shipping. 

Order printed copies online at the ASCO Store.

-------------------------------------------------------------------------------------------------------

New Technology Add-on Payment: Impact on CAR T-cell Therapy Reimbursement
On August 2, the Centers for Medicare & Medicaid Services (CMS) released the Hospital Inpatient Prospective Payment System (IPPS) final rule for fiscal year (FY) 2020.

Click here for more.

-------------------------------------------------------------------------------------------------------

CMS Expands CAR T-cell Therapy Coverage for Medicare Beneficiaries
The Centers for Medicare & Medicaid Services (CMS) announced that Medicare will now cover all Food and Drug Administration-approved Chimeric Antigen Receptor T-cell (CAR T-cell) therapy delivered in inpatient facilities.  This nationwide Medicare coverage increase for CAR T-cell therapy also opens the door for patients to receive treatment in outpatient health care facilities that are enrolled in FDS risk evaluation and mitigation strategies with expertise in delivering cellular therapies, and covers CAR T-cell therapy for off-label uses that are recommended by CMS-approved compendia.

Click here for more.

-------------------------------------------------------------------------------------------------------

Sharing Hospital Outpatient Payment Proposal Maintains 340B Cuts, Addresses Price Transparency and Prior Authorization
On July 29, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for reimbursement under the Hospital Outpatient Prospective Payment System (HOPPS) in 2020. ASCO is still analyzing the proposal and will provide more information to members as soon as possible.

Click here for more.

-------------------------------------------------------------------------------------------------------

CMS Proposes New Electronic Prior Authorization Process to Speed Access to Care

CMS recently issued a proposed rule to update and streamline the prior authorization process under Medicare Part D.  Click here for more.

------------------------------------------------------------------------------------------------------

Economic Cost of Cancer in U.S. Tops $94B Annually According to a Study
State-by-state variations in cancer deaths suggest that effective cancer prevention and treatment could yield economic benefits, according to a study published in JAMA Oncology.  Click here for more.

CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain

Agency Clarifies CDC Guideline Not Meant to Limit Access to Appropriate Pain Management for Individuals with Cancer, Sickle Cell Disease.

Click here for more.

ASTRO releases updated radiation oncology safety guide

In conjunction with Patient Safety Awareness Week, the American Society for Radiation Oncology (ASTRO)published an update today to its framework for safe and effective radiation therapy treatment. The comprehensive reference guide, Safety is No Accident: A Framework for Quality Radiation Oncology and Care, is available for download.


  • No upcoming events

News

Improving Seniors’ Timely Access to Care Act of 2019

The Mississippi Society of Oncology is proud to have joined with hundreds of other health organizations to support the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107) recently introduced by Reps. Suzan DelBene (D-WA), Mike Kelly (R-PA), Roger Marshall, MD (R-KS), and Ami Bera, MD (D-CA).

Read the letter here.

The cumulative production of 400,000 UDENYCA® pre-filled syringes is a significant milestone, as it represents approximately one-third of the annual utilization of pegfilgrastim in the United States.

Click here for more.

Janssen provides discussion paper for 2020 Medicare Hospital Inpatient Prospective Payment System (IPPS) Proposed Rule. 

The CMS fact sheet is available here.  In the FY 2020 IPPS Proposed Rule, CMS addresses how the agency proposes to pay for CAR T-cell therapy administered on an inpatient basis.

Click here for more.

Click here for more




┬ę 2008-2019  Mississippi Oncology Society.
All rights reserved | Phone: 601-909-3036

Powered by Wild Apricot Membership Software